Erste Asset Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $109K | Hold |
13,000
| – | – | ﹤0.01% | 824 |
|
|
2025
Q1 | $102K | Hold |
13,000
| – | – | ﹤0.01% | 494 |
|
|
2024
Q4 | $96.3K | Hold |
13,000
| – | – | ﹤0.01% | 504 |
|
|
2024
Q3 | $140K | Hold |
13,000
| – | – | ﹤0.01% | 489 |
|
|
2024
Q2 | $151K | Hold |
13,000
| – | – | ﹤0.01% | 484 |
|
|
2024
Q1 | $288K | Hold |
13,000
| – | – | ﹤0.01% | 464 |
|
|
2023
Q4 | $241K | Hold |
13,000
| – | – | ﹤0.01% | 477 |
|
|
2023
Q3 | $230K | Hold |
13,000
| – | – | ﹤0.01% | 470 |
|
|
2023
Q2 | $258K | Hold |
13,000
| – | – | ﹤0.01% | 473 |
|
|
2023
Q1 | $235K | Hold |
13,000
| – | – | ﹤0.01% | 480 |
|
|
2022
Q4 | $297K | Hold |
13,000
| – | – | 0.01% | 459 |
|
|
2022
Q3 | $324K | Hold |
13,000
| – | – | 0.01% | 469 |
|
|
2022
Q2 | $315K | Hold |
13,000
| – | – | 0.01% | 473 |
|
|
2022
Q1 | $430K | Hold |
13,000
| – | – | 0.01% | 451 |
|
|
2021
Q4 | $426K | Hold |
13,000
| – | – | 0.01% | 438 |
|
|
2021
Q3 | $547K | Hold |
13,000
| – | – | 0.01% | 393 |
|
|
2021
Q2 | $500K | Hold |
13,000
| – | – | 0.01% | 411 |
|
|
2021
Q1 | $437K | Hold |
13,000
| – | – | 0.01% | 394 |
|
|
2020
Q4 | $604K | Hold |
13,000
| – | – | 0.02% | 373 |
|
|
2020
Q3 | $363K | Hold |
13,000
| – | – | 0.01% | 370 |
|
|
2020
Q2 | $480K | Hold |
13,000
| – | – | 0.02% | 345 |
|
|
2020
Q1 | $439K | Hold |
13,000
| – | – | 0.03% | 316 |
|
|
2019
Q4 | $527K | Hold |
13,000
| – | – | 0.02% | 325 |
|
|
2019
Q3 | $434K | Hold |
13,000
| – | – | 0.02% | 328 |
|
|
2019
Q2 | $646K | Hold |
13,000
| – | – | 0.03% | 292 |
|
|
2019
Q1 | $722K | Buy |
+13,000
| New | +$722K | 0.04% | 276 |
|